Five-year experience in the treatment of alopecia areata with DPC

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 3, 2010, Pages 264-269

  El Zawahry, B M ^a   Bassiouny, D A ^a   Khella, A ^a   Zaki, N S ^a  

^a Cairo University   (Egypt)

Author keywords

Alopecia areata; Diphencyprone; Immunotherapy; Long term follow up

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHENCYPRONE; STEROID; SUNSCREEN; CYCLOPROPANE DERIVATIVE; POWDER;

ADOLESCENT; ADULT; ALOPECIA AREATA; ALTERNATIVE MEDICINE; ARTICLE; BLISTER; CHILD; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HAIR GROWTH; HAIR LOSS; HUMAN; HYPERPIGMENTATION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REST; RISK REDUCTION; SCALP; SCHOOL CHILD; SKIN IRRITATION; STEROID THERAPY; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VITILIGO; COMPARATIVE STUDY; DOSE RESPONSE; IMMUNOTHERAPY; INFANT; MIDDLE AGED; PATHOLOGY; PATIENT SATISFACTION; POWDER; PROCEDURES; RETROSPECTIVE STUDY; TIME; TOPICAL DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; CYCLOPROPANES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INFANT; MALE; MIDDLE AGED; PATIENT SATISFACTION; POWDERS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76349119929     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03401.x     Document Type: Article

References (26)

1. Daman LA, Rosenberg EW, Drake L. Treatment of alopecia areata with dinitrochlorobenzene. Arch Dermatol 1978 114 : 1036 1038.
2. Case PC, Mitchell AJ, Swanson NA, Vanderveen EE, Ellis CN, Headington JT. Topical therapy of alopecia areata with squaric acid dibutylester. J Am Acad Dermatol 1984 10 : 447 450.
3. Caserio RJ. Treatment of alopecia areata with squaric acid dibutylester. Arch Dermatol 1987 123 : 1036 1041.
4. Orecchia G, Malagoli P, Santagostino L. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients. Pediatr Dermatol 1994 11 : 65 68.
5. Gordon PM, Aldrige RD, McVittie E, Hunter JA. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up. Br J Dermatol 1996 134 : 869 871.
6. Hull SM, Cunliffe WJ. Successful treatment of alopecia areata using the contact allergen diphencyprone. Br J Dermatol 1991 124 : 212 213.
7. Hull SM, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol 1991 125 : 164 168.
8. Orecchia G, Rabbiosi G. Treatment of alopecia areata with diphencyprone. Dermatologica 1985 171 : 193 196.
9. Pericin M, Trueb RM. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases. Dermatology 1998 196 : 418 421.
10. Sotiriadis D, Patsatsi A, Lazaridou E, Kastanis A, Vakirlis E, Chrysomallis F. Topical Immunotherapy with Diphencyclopropenone in the treatment of chronic extensive alopecia areata. Clinical and Experimetal Dermatology, 2006 32 : 48 51.
11. Hull SM, Norris JF. Diphencyprone in the treatment of long-standing alopecia areata. Br J Dermatol 1988 119 : 367 374.
12. van der Steen PH, van Baars HM, Perret CM, Happle R. Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991 24 : 253 257.
13. Happle R, Hausen BM, Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol 1983 63 : 49 52.
14. van der Steen PH, van Baar HM, Happle R, Boezeman JB, Perret CM. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991 24 : 227 230.
15. van der Steen PH, Boezeman JB, Happle R. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months. Dermatology 1992 184 : 198 201.
16. Ashworth J, Tuyp E, Mackie RM. Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis: a comparison of the value of topical diphencyprone and tretinoin gel. Br J Dermatol 1989 120 : 397 401.
17. Paus R, Nickoloff BJ, Ito T. A 'hairy' privilege. Trends Immunol 2005 26 : 32 40.
18. Happle R, Klein H, Macher E. Topical immunotherapy changes in the composition of the peribulbar infiltrate in alopecia areata. Arch Dermatol Res 1986 278 : 214 218. (Pubitemid 16106520)
19. Brocker EB, Echternacht-Happle K, Hamm H, Happle R. Abnormal expression of class I and class II major histocompatability antigens in alopecia areata modulation by topical immunotherapy. J Invest Dermatol 1987 88 : 564 568.
20. Happle R, Kalveran K, Buchner U, Echternacht-Happle K, Goggelman W, Summer KH. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester. Dermatologica 1980 161 : 289 297.
21. Costellessa C, Peris K, Caracciolo E, Mordenti C, Chimenti S. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol 2001 44 : 73 76.
22. Friedli A, Harms M. Alopecia areata. Ther Umsch 2002 59 : 233 237.
23. Wiseman MC, Shapiro J, MacDonald N, Lui H. Predictive model for immunotherapy of alopecia areata with Diphencyprone. Arch Dermatol 2001 137 : 1063 1068.
24. Hull SM. Post-therapy relapse rate in alopecia areata after successful treatment with Diphencyprone. J Dermatol Treat 1989 1 : 71 74.
25. Hull SM, Norris JF. Diphencyprone in the treatment of long-standing alopecia areata. Br J Dermatol 1988 119 : 367 374.
26. Aghaei S. Topical immunotherapy of severe alopecia areata with DPCP: 3xperience in an Iranian population. BMC Dermatol 2005 5 : 6.